Updated:
Corundum Systems Biology
Corundum Systems Biology provides support for microbiome research and business development. The company aids in global microbiome advancements through...
Overview
Corundum Systems Biology provides support for microbiome research and business development. The company aids in global microbiome advancements through business development, biometric database and data analysis platform development, and grant funding for R&D. Corundum Systems Biology has made seven investments, including a Series A investment in Sequential on March 16, 2026.
General information
Firm type
Generalist
Year founded
2020
Location
Region
Asia
Country
Japan
City
Tokyo
Corporate office
Tokyo, Japan
Sector focus
Frequently asked questions
Does Corundum Systems Biology invest outside Japan?
The firm is headquartered in Tokyo, and its primary deal flow is assumed to be Japan-centric. There is no public record confirming dedicated offices or funds for other Asian geographies, though early-stage Japanese investors occasionally participate in pan-Asian syndicates.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: